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INTRODUCTION
Hemoglobin (Hb) is one of the most abundant proteins in the
human body and the major component of erythrocytes,
supporting their basic function as oxygen and carbon dioxide
transporters. The erythrocyte life span is about 120 days.
Thereafter, the senescent cells are removed from circulation by
mononuclear phagocyte cells. However, the process is not
complete and free hemoglobin is released into the circulation to
a certain extent. After dissociation, dimeric Hb is complexed
with plasma glycoprotein haptoglobin (Hp), while the
undissociated tetrameric form remains in the circulation. Uptake
of free Hb and Hp-Hb largely occurs in the liver (1, 2). Any
excess of free hemoglobin is also rapidly removed by the kidney
after glomerular filtration (3, 4).
Research into the molecular mechanism of hepatic clearance
of these compounds has been in progress since the early 60’s,
and for decades has provided ambiguous or even contradictory
results. One controversy was the cell type responsible for these
processes. In some studies, uptake has been observed
exclusively either in hepatocytes or in Kupffer cells, while in
others it has been noted in both types of cells. There are also
discrepancies concerning whether free Hb can be endocytosed
by liver cells, or only when complexed with Hp.
Using histochemistry, Goldfischer et al. (5) demonstrated
the presence of Hb in lysosomes of both hepatocytes and
Kupffer cells after intravenous administration to rats.
Hemoglobin uptake by hepatocytes has also been observed in
studies using 3H-Hb and autoradiography in mice (6). Kino et al.
(7) found an accumulation of intravenously administered 59Fe-
Hb-Hp in rat liver and binding of 125I-Hb-Hp complex to the
isolated membranes of hepatocytes. Subsequent studies by these
authors have confirmed the uptake of Hp-Hb complex in
hepatocytes via immunohistochemistry; however, the studies
have failed to demonstrate internalization of the Hp-Hb complex
by isolated hepatocytes. The authors have suggested that the
receptor for the Hp-Hb complex is sensitive to proteolysis and
undergoes inactivation during isolation of hepatocytes using
collagenase (8, 9). In our studies (10), hepatocytes have been
isolated via liver perfusion with EDTA. The cells were able to
both bind and internalize fluorescently labeled Hp-Hb. The
determined dissociation constant for the binding reaction was
1.2 µM, and the binding was inhibited by anti-Hb antibodies.
The internalization of the complex was dependent on the
presence of ATP and its rate was accelerated by increasing GTP
concentrations. In further studies, we have also found that
isolated hepatocytes bind not only the Hp-Hb complex but also
free Hb. Both labeled Hb and Hb-Hp were displaced by
unlabeled Hb, suggesting that at least part of the structure
recognized by the receptor is located in the Hb molecule. The
binding protein was partially purified from the solubilized
hepatocytes using affinity chromatography on a bed with
conjugated hemoglobin. Due to the preparation on a small scale,
we were not able to identify and characterize the protein (11).
Just recently that research was able to shed some light on this
issue. It was demonstrated that CD163, a protein belonging to
the superfamily of cysteine-rich scavenger receptors (SRCR-
SF), is the functional receptor for the Hb-Hp complex. The
protein had been discovered much earlier in the course of
research on macrophage differentiation antigens, but its basic
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function had remained unknown for a long time (12). The role of
CD163 in the catabolism of hemoglobin was later confirmed by
Schaer et al. (13), who found that not only the Hp-Hb complex
but also free Hb is bound by the receptor. It should be stressed,
however, that the expression of this receptor is limited only to
the mononuclear-phagocytic cells, which in the liver are
represented exclusively by Kupffer cells. Since these cells
represent only a very small fraction of liver cells, the role of
CD163 in the gross clearance of hemoglobin is open to question.
Thus, it is believed that the physiological roles of these
interactions are associated with receptor-mediated
immunomodulation during late-stage acute or chronic
inflammation (14, 15). Recent studies have also demonstrated
that there are major differences in CD163-dependent scavenging
systems between species, which may explain discrepancies
observed by researchers in the past (16).
Our study, carried out at a later stage (17) in mice, reaffirmed
Hb uptake by hepatocytes. Furthermore, internalization of the
protein occurred in both wild-type and Hp knockout mice, in
which the Hp pathway is obviously abolished. This prompted us
to perform a detailed study aiming at the identification of
hemoglobin binding protein(s) present on the hepatocyte plasma
membrane.
MATERIALS AND METHODS
Materials
Isolated rat cryopreserved hepatocytes were purchased from
Invitrogen (Carlsbad, CA, USA). Rat and human hemoglobin
were prepared from whole blood, as described previously (18).
HepG2 cells were purchased from the Department of
Embryology and Histology (Wroclaw Medical University,
Poland).
Detection of hemoglobin receptors using the label transfer
technique
SBED reagent was used to perform the label transfer
technique. This compound is a cross-linking reagent containing
two chemically-reactive groups and a biotin residue. Sulfonated
N-hydroxysuccinimide ester reacts with primary amines and,
thus, biotinylates the ‘bait’ protein (Hb). During the second step,
photosensitive aryl azide moiety captures the target protein
(putative Hb receptor). After reduction of the disulfide bridge,
located on the N-linker side, the biotin label is transferred to the
captured molecule. The released labeled receptor can be detected
using streptavidin-peroxidase.
Human Hb was conjugated via amine groups to the tri-
functional cross-linking agent sulfosuccinimidyl-2-[6-
(biotinamido)-2-(p-azidobenzamido)-hexanoamido]-ethyl-1,3’-
dithiopropionate (sulfo-SBED; Thermo Fisher Scientific,
Waltham, MA) according to the manufacturer’s instructions. The
labeled hemoglobin is further referred to as SBED-Hb. Human
hepatocellular carcinoma HepG2 cells were used as an in vitro
model system for the experiment. The cells were routinely
grown in MEM medium (Gibco/Life Technologies, Waltham,
MA, USA) supplemented with 10% FCS (Lonza, Basel,
Switzerland) and 1% L-glutamine-penicillin-streptomycin
solution (Sigma). The cells were incubated at 37°C in a
humidified atmosphere with 5% CO2. For experiments, the cells
were harvested using 0.05% Trypsin-EDTA solution (Sigma-
Aldrich, Germany) and seeded at a density of approximately 25
× 104 cells/ml (12 ml) in Cellstar Petri dishes 145 × 20 mm
(Greiner Bio One, Kremsmunster, Austria). The cells were
grown to confluence over a period of 7 days and the media were
changed every second day. On the day of the experiment, the
cells (1.6 × 107) were washed three times in MEM without FCS
and L-glutamine-penicillin-streptomycin solution and incubated
with fresh medium without supplements for 1 hour.
For association of SBED-Hb with its cell receptors, the
labeled protein (5 mg in 10 ml of growth medium) was added
to the cells and the dishes were incubated in the dark at 37°C
for 60 min. Unbound SBED-Hb was removed by washing with
cold PBS. Cross-linking was achieved by exposure of the cells
to long-wavelength UV light (365 nm) for 20 min at a distance
of 5 cm on ice (except for the control dish). The cells were
briefly washed two times with cold PBS, harvested by scraping
in 3 ml of cold PBS with protease inhibitor cocktail and
pelleted via centrifugation at 1000 × g for 5 min. Plasma
membrane proteins were isolated using a ProteoExtract Native
Protein Extraction Kit (Merck, Darmstadt, Germany),
according to the manufacturer’s instructions. The membrane
proteins were analyzed by using NuPage 3 – 8% tris-acetate
precast gels (Invitrogen, Carlsbad, CA) under reducing (100
mM dithiothreitol) or non-reducing conditions. The
biotinylated proteins were detected via Western blotting
method using horseradish peroxidase (HRP)-labeled
streptavidin and an enhanced chemiluminescence reagent
(Pierce, Rochester, IL, USA).
Isolation of membrane proteins
The total plasma membrane protein fraction (TM) and total
surface protein fraction (TSM) of rat hepatocytes were isolated
using a ProteoExtract ® Native Membrane Protein Extraction
Kit and a Cell Surface Protein Isolation Kit (Merck, Darmstadt,
Germany), respectively, according to the manufacturer’s
protocols.
Binding of hemoglobin to plasma membrane proteins by
surface plasmon resonance (SPR)
The analysis was performed on a BIAcore 1000 analytical
system, using a CM5 sensor chip (Biacore AB, Uppsala, Sweden)
at 25 ± 0.1°C operating temperature with HBS (10 mM HEPES,
150 mM NaCl, and 0.05% surfactant P20, pH 7.4) as a mobile
phase. An amine coupling kit was used to activate the
carboxymethylated dextran surface of the sensor chip.
Immobilization of the ligand was achieved via injection of TM
(50 µl in 0.05 M sodium acetate buffer, pH 4.5 at 10 µl/min).
Residual N-hydroxysuccinimide esters were inactivated with 1 M
ethanolamine. For experiments, rat Hb (25 µM in HBS) was
injected over the surface for the association phase. The surface
was regenerated via subsequent washes with 10 mM HCl, 100
mM glycine and 10 mM NaOH.
Isolation of hemoglobin receptor with affinity chromatography
Rat Hb (5 mg) was immobilized via amine groups on 
1 ml NHS-activated HiTrap Sepharose matrix (GE Healthcare,
USA). The protein preparations (TM or TSM) were recirculated
at 0.2 ml/min flow through an Hb-HiTrap Sepharose column
equilibrated with PBS (pH 7.4), 1 mM CaCl2, and 0.5% CHAPS
for 2 hours. The column was washed with 30 ml PBS (pH 7.4),
1 mM CaCl2, 0.5% CHAPS, 30 ml of the same buffer containing
0.5 M NaCl, and again with 10 ml of the first buffer. Bound
proteins were eluted with 6 M urea in PBS pH 7.4 containing
0.5% CHAPS. For the control experiments, a ligand free column
was used. Amine reactive sites on the bed were blocked with 1M
ethanolamine for 1 hour, at 25°C. Collected 1-ml fractions were
analyzed in sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) using NuPage 3 – 8% tris-acetate
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precast gels under reducing conditions (Invitrogen, Carlsbad,
CA, USA). Protein bands were visualized with GELCODE blue
stain reagent (Pierce Biotechnology, Rochester, IL, USA).
Protein identification via mass spectrometry
The receptor proteins isolated via affinity chromatography of
the TSM fraction were identified using peptide mass
fingerprinting analysis. After separation of proteins with SDS-
PAGE followed by in-gel protein staining, the bands were
excised and subsequently destained in 25% and 50% acetonitrile.
The proteins were reduced and alkylated using 50 mM DTT and
10 mg/ml iodoacetamide. Digestion was performed using 10
ng/ml trypsin. The peptides were subsequently extracted using
10% TFA and 100% ACN, and dried. Before chromatography, the
samples were resuspended in 2% ACN and 0.05% TFA, and
centrifuged at 30,000 g for 30 min.
Peptides were separated using an Ultimate 3000RS
LCnanoSystem (Dionex) chromatograph, and analyzed online
using a microTOF-QII spectrometer (Bruker, Germany)
equipped with an Appollo Source nano-ESI sprayer and a C18
guard column (Acclaim PepMap Nano Trap Column). Two
percent ACN with 0.05% TFA was used as the mobile phase.
Proper separation was performed on a 15 cm × 75 microns RP
column (Acclaim PepMap 75 microns 100 Å Nano Series
ColumnTM) using a 40-minute gradient of 2 – 40% ACN with
0.05% FA. The spectrometer worked in standard DDA (date-
dependent acquisition) mode, in which 3 precursors were
subjected to the most intense fragmentation.
MS data were searched against the rodent sequences of the
Swiss-Prot database using the Mascot search engine (v.3.0,
Matrix Science, London, UK). The following search parameters
were used: specificity of the enzyme-trypsin, allowed number of
abandoned sites cut-1, modification-carbamidomethyl (Cys),
variable modification-oxidation (Met), weight range-
unrestricted, peptide mass tolerance of the precursor ± 20 ppm,
ion fragment tolerance ± 0.05 Da.
Kinetics of hemoglobin binding to ATPB
Kinetics of hemoglobin-ATPB complex formation was
analyzed via the fluorescence quenching technique using an
LS50B spectrofluorimeter (Perkin Elmer, Waltham, MA, USA).
All experiments were performed in PBS containing 2% glycerol
in 5 × 5 mm cuvettes at 25°C. Excitation wavelength was set for
280 nm. The emission was scanned within a 300 – 400 nm range
using emission and excitation slits of 10 and 5 nm, respectively.
In preliminary experiments, hemoglobin at a final
concentration of 0.06 µM was incubated with ATPB (0.3 µM)
and fluorescence emission was scanned every 5 min for a 1-hour
period. The equilibrium of the complex Hb-ATPB formation was
fully achieved within a 10-minute period.
For kinetic analysis, additions of hemoglobin (quencher)
were made from stock solution (75 µM) to a cuvette (650 µl)
containing 0.3 µM ATPB. After 10 min incubation, three
subsequent scans were recorded. Scans were corrected by
subtraction of the fluorescence signal recorded for the incubation
buffer. Saturation binding curves were constructed using values
recorded at 303 nm, the wavelength corresponding to the
maximal emission of tyrosine residues. Dissociation constants
(Kd) were evaluated via computerized non-linear regression
analysis using GraphPad Prism software (GraphPad, USA)
according to the one-site binding model corrected for ligand
depletion effect (receptor concentration < 0.2 Kd) and quencher
addition effect connected with intrinsic Hb fluorescence (19). A
complementary experiment was performed with BSA as a non-
binding ligand counterpart.
RESULTS
To achieve a preliminary characterization of the Hb binding
components present in the hepatocyte membrane, we performed
a study using the label transfer technique in hepatocyte derived
cell line HepG2 (Fig. 1). Human Hb was conjugated to the
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Fig. 1. Detection of the putative
hepatocyte Hb receptor by using the
biotin label transfer technique and
Western-blotting. Hb was conjugated to
the trifunctional cross-linking agent
containing an amine linker, biotin label
and photo-inducible aryl azide group
(sulfo-SBED). SBED-Hb (bait protein)
was incubated with the HepG2 cells.
The putative Hb receptor (pray protein)
was captured by photoactivation of the
aryl azide moiety linked via cleavable
disulfide bond to Hb). The biotin
residue of SBED-Hb (lane 1) is fully
split under reducing conditions (lane 4).
The complex SBED-Hb-putative
receptor is seen as ~120 kDa band (lane
2). After reduction of the disulfide
bridge, the biotin label is transferred to
the captured ~50 kDa Hb receptor (lane
5). The bands are not seen in the control
experiment without a photoactivation
step (lane 3 and 6). Biotin was
visualized using an HRP-streptavidin
conjugate and chemiluminescent
detection.
trifunctional cross-linking agent containing an amine linker,
biotin label and photoinducible aryl azide group (sulfo-SBED).
Under non-reducing conditions, SBED-Hb conjugate could be
easily detected using a streptavidin-peroxidase reagent. In the
main, a hemoglobin dimer band was visible (Lane 1). Complete
splitting of the biotin moiety occurred after reduction (Lane 4).
The cells were first incubated with SBED-Hb at 37°C for 60 min
in the dark. Following incubation, unbound SBED-Hb was
removed, the cells were washed, and exposed to long-
wavelength UV light in order to activate the aryl azide moiety
and, consequently, cross-link the Hb-receptor complex. In the
control experiment, the photo-induction step was omitted.
Transmembrane protein fractions were isolated from the cells
and analyzed via Western-blotting method. A 120 kDa band
corresponding to the cross-linked Hb-receptor complex was seen
under non-reducing conditions (Lane 2). Under reducing
conditions, the band had lower intensity and a new ca. 50 kDa
band appeared, corresponding to the labeled receptor (Lane 5).
This was consistent with the splitting of the disulfide bridge in
the cross-linked complex and the transfer of the biotin label to
the receptor molecule. The shift in molecular mass coincides
with the mass of the released tetrameric Hb (66 kDa). Neither
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Fig. 2. Characterization of
hemoglobin binding to the hepatocyte
membrane protein fraction by SPR.
Hb (analyte) was passed over total
hepatocyte membrane proteins
(ligands) immobilized on a sensor
chip. Associated Hb was released by
acidic treatment (10 mM HCl) in only
ca. 30%. Mild alkaline treatment (100
mM Gly) did not support further
release. Full dissociation was
achieved under strong alkaline
conditions (10 mM NaOH). The SPR
signal is presented as the mass
equivalent response units (RU).
Fig. 3. Affinity chromatography of
hepatocyte plasma membrane
proteins. Chromatography was
performed on a bed with (lanes 3, 6)
or without (lanes 4, 7) immobilized
hemoglobin. (lane 1) molecular
weight markers; (lane 2) total plasma
membrane proteins; (lanes 3, 4)
affinity isolated protein fraction
extracted from total plasma
membrane proteins; (lane 5) total
surface protein fraction; (lanes 6, 7)
affinity isolated protein fraction
extracted from total surface protein
fraction. The fractions were analyzed
in SDS-PAGE. Gels were stained
using colloidal Coomassie Brilliant
Blue.
120 kDa nor 50 kDa bands were present in the preparations
obtained from the control experiment (Lanes 3 and 6). The bands
seen in lanes 5 and 6 in the range of 65 – 70 kDa presumably
represent non-specific binding of streptavidin to a non-identified
cell membrane component.
Next, we established the optimal conditions for isolation of
the hepatocyte hemoglobin receptor in the SPR study. Total
protein membrane fractions from the isolated rat hepatocytes
were used. The proteins were coated covalently on a sensor chip
and rat hemoglobin was passed over as an analyte (Fig. 2).
Substantial binding of hemoglobin occurred, as was seen by a
baseline shift of about 250 RU. The affinity of the interaction
was in the nanomolar range (Kd = 9.14 × 10–7 M) when the
curves were analyzed according to the one-site binding model.
The strength of the interaction was substantial enough to
approach the isolation of the receptor using affinity
chromatography. The binding could not be completely released
in acidic conditions (10 mM HCL, 100 mM Gly). Additional
basic treatment (10 mM NaOH) was needed in order to fully
dissociate the complex. Therefore, we decided to use a strong
chaotropic agent-urea-as an eluent in affinity chromatography.
Two different hepatocyte protein preparations were
employed for isolation of the receptor: (i) the total plasma
membrane protein fraction, and (ii) the surface protein fraction.
The fractions were passed over the column containing the
hemoglobin-matrix and the eluates were analyzed by using SDS-
PAGE. Both fractions yielded the same major band,
corresponding to a molecular mass of about 50 kDa (Fig. 3).
There were no bands visible in the control experiments using a
bed without hemoglobin (Fig. 3).
The results from the label transfer experiment and affinity
chromatography were consistent, and indicated that the putative
Hb receptor is a protein with a molecular mass of ca. 50 kDa.
The purified protein was subjected to peptide mass
fingerprinting analysis for identification. Two predominant
components were detected in the preparation: F1-ATPase
subunit alpha (ATPA) and beta (ATPB). The details of the
analysis are presented in Table 1. Both the signal score (1745 –
1759 AU) and the sequence coverage (53 – 69%) for these two
proteins were relatively high, confirming the validity of the
analysis. The other minor components of the fraction, due to
their relatively poor scores, can be considered non-specific
contaminations, presumably originating from the endoplasmic
reticulum.
In a further study, the binding of Hb to F1-ATPase was
verified using recombinant rat ATPB. The purity of the protein
was verified via SDS-PAGE (not shown). There was no
contamination in the preparation. The interaction of purified
proteins was examined using the fluorescence quenching
technique. Increasing amounts of pure hemoglobin or BSA in a
minimal volume were added to a reaction cuvette containing 0.3
µM ATPB or binding buffer alone (control). BSA was used as a
non-binding protein counterpart. Since ATPB does not contain
tryptophan residues, the intrinsic fluorescence of tyrosine
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Fig. 4. Quenching of ATPB intrinsic fluorescence by Hb. Increasing amounts of pure hemoglobin (A) or BSA (B) in the minimal
volume were added to a reaction cuvette containing ATPB. BSA was used as a non-binding protein counterpart (negative control).
Fluorescence emission at 303 nm (excitation wavelength of 280 nm) was recorded. Additive quenching of fluorescence is seen with
Hb addition indicating complex formation, while no quenching is observed with BSA addition.
 
Protein identified Mr [kDa] Score # Peptides S.C. [%] 
ATPase alpha subunit (ATPA_RAT) 59.7 1759 20 52.8 
ATPase beta subunit (ATPB_RAT) 56.3 1745 24 69.4 
Trifunctional enzyme subunit beta 
(ECHB_RAT) 
51.4 420 7 29.7 
Cytochrome P450 2C23 
(CP2CN_RAT) 
56.4 281 6 16.2 
Fatty aldehyde dehydrogenase 
(AL3A2_RAT) 
54.0 224 4 11.6 
Table 1. Hb receptor proteins isolated by affinity chromatography and identified by mass spectrometry.
residues was recorded at an excitation wavelength of λex = 280
nm. Fluorescence emission spectra were recorded in the range
from 300 nm to 400 nm. The values recorded at 303 nm (the
maximum emission for tyrosine residues) were extracted for
further analyses. There was an additive fluorescence signal rise
when increasing the concentration of pure hemoglobin in the
binding buffer, indicating that the inner quenching effect did not
affect the measurements. In contrast, significant fluorescence
quenching was observed when increased amounts of
hemoglobin was added to ATPB (Fig. 4A). Such a fluorescence
shift is in accordance with changes in the environment of
tyrosine residues due to conformational changes in the course of
complex formation between the two proteins (dynamic-static
quenching). As in the case of hemoglobin, increasing the BSA
concentration in binding buffer alone gave rise to the
fluorescence emission signal in a dose-dependent manner.
However, no quenching of fluorescence was observed when
BSA was added to ATPB, indicating no complex formation (Fig.
4 B). Therefore, the interaction between Hb and ATPB seems to
be relatively specific.
The kinetics of the complex dissociation were evaluated via
non-linear regression analysis. Hb binding to ATPB exhibited
saturable binding kinetics (Fig. 5). Fitting the curve according to
the one-site binding model yielded Kd of 7.5 × 10–7 M. The
affinity was in close accordance with the data obtained with a
crude membrane protein fraction using SPR (Kd = 9.1 × 10–7 M).
DISCUSSION
Uptake of hemoglobin by hepatocytes and the presence of
specific binding sites on the hepatocyte membrane have been
repeatedly reported over the last half century. However,
research has so far failed to identify the specific Hb receptor in
these cells.
In the present study, we have isolated the hepatocyte Hb
receptor on the Hb matrix via affinity chromatography using two
different membrane protein preparations obtained from isolated
rat hepatocytes. The first method, based on specific non-
detergent extraction, has previously been reported to yield pure
membrane proteins, free of other subcellular protein
contaminations, and has proved to be superior than the five
currently used protocols (20). The second method employed
surface biotinylation of whole cells as the first step and
subsequent streptavidin-based extraction, ensuring that only
surface plasma membrane proteins are captured. Both
preparations yielded the same two major protein components.
The proteins were identified via mass spectrometry as F1-
ATPase alpha (ATPA) and beta (ATPB) subunits. It is well
documented that F1-ATPase is expressed in the plasma
membrane, in addition to its mitochondrial expression. Both the
ectopic and mitochondrial forms seem to be identical as regard
to the structure and stoichiometry of subunits (21, 20). The
plasma membrane expression of F1-ATPase is linked to different
biological activities, such endocytosis/regulation of HDL uptake
by hepatocytes, endothelial cell proliferation, and antitumor
activity of T lymphocytes. Currently, only a few ligands for the
receptor have been identified, i.e. apoA1, MHC1 antigen,
angiostatin, amyloid beta peptide and juvenile hormone binding
protein. Although it is known from recent studies that the whole
F0F1 complex is present in the plasma membrane, the receptor
activities are attributed to the F1 part of the complex (22, 23).
Consistently, we observed hemoglobin binding to both
components of the F1 complex (alpha and beta subunits).
Using pure recombinant rat ATPB and Hb, we estimated the
dissociation constant for the complex (Kd = 7.5 × 10–7 M). The
value was close to that obtained using the total protein
membrane fraction of hepatocytes analyzed via the SPR method
(Kd = 9.1 × 10–7 M) and that reported in our previous study (10)
using EDTA-prepared hepatocytes (Kd = 1.2 × 10–6 M). As
previously reported (24), the concentration of free hemoglobin
in normal plasma fell into the same range (~0.5 × 10–6 M).
Therefore, the interaction of hemoglobin and F1-ATPase may be
relevant for the hepatic uptake of the protein in physiological
state. The other Hb uptake system involving megalin/cubilin
tandem receptors, operating with similar affinity (Kd = 1.7 – 4.1
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Fig. 5. Saturation binding curve of
hemoglobin binding to F1-ATPase beta
subunit. Association was examined
using the fluorescence quenching
technique. Increasing amounts of pure
Hb in the minimal volume were added
to a reaction cuvette containing 0.3
µmol ATPB. Kd was evaluated by non-
linear regression according to the one-
site binding model. The data are
presented as mean ± standard errors
from three measurements.
× 10–6 M), has proved to be efficient for complete extraction of
the protein in the renal proximal tubule (4). In hemolytic
disorders the concentration of hemoglobin can be elevated
several times. Under these circumstances, rapid complex
formation can be expected. Thus, the pathway might be
responsible for the massive loading of hemoglobin into the cells,
and consequently liver toxicity observed during extensive
hemolysis or hemoglobin-based blood substituent infusions.
It seems that ectopic F1-ATPase does not perform the role of
classical scavenger receptor, but rather it is a regulatory protein
that induces endocytic processes in the hepatocyte. In the case of
HDL/ApoA1, the enzyme acts in concert with the P2Y13 receptor
to facilitate endocytic uptake of these ligands. Hydrolysis of ATP
to ADP by F1-ATPase stimulates the P2Y13 receptor signaling,
dependent on small RhoA GTPase that results in the uptake of
the HDL particles. We observed similar characteristics for Hb
uptake by cultured isolated hepatocytes in our previous study.
Internalization of Hb was dependent on ATP and stimulated by
GTP addition to the medium (10). The exact molecular
mechanism of F1-ATPase driven endocytosis has not yet been
revealed. It is not known whether ectopic ATPase undergoes
internalization and recycling. Also, adaptor proteins associated
with the receptor have not been identified. Since the receptor
seems to be associated with membrane lipid rafts, it can be
speculated that a clathrin-independent mode of endocytosis
underlies this phenomenon.
Due to the significant prevalence of hemolytic diseases, this
finding may be very important for future studies into the
pathogenesis of acute hemolysis complications. Our results may
also be important for the development of safe blood substitutes
based on hemoglobin for use in medical intervention.
In addition, due to the abundant presentation of ectopic F1-
ATPase on hepatocyte cells, the receptor could be a very
promising target molecule for specific delivery of drugs in
treatment of liver diseases. Antioxidant, antiinflamatory and
antiapoptotic agents seem to be effective in attenuation of liver
injure in several experimental models of chemical intoxication
and hepatitis, and could be possibly directed to hepatocyte cells
via this interaction (25). On the other hand, maneuvers targeting
proteins associated with endocytosis and autophagy are
considered as new strategies in anticancer therapy (26, 27).
In the present study, we have identified for the first time the
fact that ectopic F1-ATPase is the receptor for hemoglobin on
the hepatocyte plasma membrane. We suggest that the receptor
is involved in hemoglobin uptake by hepatocytes. Since ectopic
F1-ATPase is not internalized itself, it seems that its role is
limited to a regulatory function in the endocytic processes.
Further studies are needed to explain the exact role of the
receptor in physiological and pathological states.
Abbreviations: ACN, acetonitrile; ATPA, F1-ATPase subunit
alpha; ATPB, F1-ATPase subunit beta; DTT, dithiotreitol; Hb,
hemoglobin; Hp, haptoglobin; SDS-PAGE, sodium dodecyl
sulfate polyacrylamide gel electrophoresis; SPR, suface plasmon
resonance; Sulfo-SBED, sulfosuccinimidyl-2-[6-(biotinamido)-2-
(p-azidobenzamido)-hexanoamido]-ethyl-1,3’-dithiopropionate;
TFA, trifluoroacetic acid.
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